Bio-Rad Laboratories (BIO-B) Retained Earnings (2009 - 2026)
Bio-Rad Laboratories (BIO-B) reported Retained Earnings of -$235.4 million for Q1 2026, down 103.15% year-over-year from $7.5 billion in Q1 2025, and down 24.48% quarter-over-quarter from -$189.1 million in Q4 2025.
Bio-Rad Laboratories (BIO-B) Retained Earnings (2009 - 2026) Analysis & Trends
Bio-Rad Laboratories (BIO-B) has 18 years of Retained Earnings data on file, last reported at -$235.4 million in Q1 2026.
- Retained Earnings for Q1 2026 came in at -$235.4 million, down 103.15% year-over-year; the trailing twelve-month figure through Mar 2026 was -$235.4 million (down 103.15% YoY), and the FY2025 annual result was -$189.1 million, down 102.55% from the prior year.
- Retained Earnings slipped to -$235.4 million in Q1 2026 per BIO-B's latest filing, from -$189.1 million in the prior quarter.
- Over five years, Retained Earnings peaked at $7.5 billion in Q1 2025 and troughed at -$823.8 million in Q3 2022.
- A 5-year average of $1.6 billion and a median of -$10.6 million in 2022 frame the typical range for Retained Earnings.
- The sharpest annual moves came in 2024 and 2025: Retained Earnings plunged 5899.59% in 2024, then soared 2465.02% in 2025.
- A 5-year view of Retained Earnings shows it stood at -$10.3 million in 2022, then slumped by 3162.14% to -$336.0 million in 2023, then surged by 2307.26% to $7.4 billion in 2024, then plunged by 102.55% to -$189.1 million in 2025, then dropped by 24.48% to -$235.4 million in 2026.
- Business Quant data shows BIO-B's Retained Earnings at -$235.4 million in Q1 2026, -$189.1 million in Q4 2025, and $7.5 billion in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 49.96 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | -583.00 Mn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 32.30 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | -398.00 Mn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | -221.30 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 106.20 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 5.65 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | -113.10 Mn |
| 10 | Bio-Rad Laboratories | - | - | 309.40 Mn | -235.40 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -235.40 Mn |
| Dec 31, 2025 | -189.10 Mn |
| Sep 30, 2025 | 7.46 Bn |
| Jun 30, 2025 | -154.10 Mn |
| Mar 31, 2025 | 7.48 Bn |
| Dec 31, 2024 | 7.42 Bn |
| Sep 30, 2024 | -315.27 Mn |
| Jun 30, 2024 | 7.48 Bn |
| Mar 31, 2024 | -425.97 Mn |
| Dec 31, 2023 | -336.00 Mn |
| Sep 30, 2023 | -6.60 Mn |
| Jun 30, 2023 | -374.70 Mn |
| Mar 31, 2023 | -7.10 Mn |
| Dec 31, 2022 | -10.30 Mn |
| Sep 30, 2022 | -823.80 Mn |
| Jun 30, 2022 | -10.40 Mn |
| Mar 31, 2022 | -10.60 Mn |
| Dec 31, 2021 | -170.50 Mn |
| Sep 30, 2021 | -48.50 Mn |
| Jun 30, 2021 | 140.40 Mn |